ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)

Neuroendocrinology

Volumn 103, Issue 2, 2016, Pages 144-152

  Pape, Ulrich Frank ^a   Niederle, B ^b   Costa, F ^c   Gross, D ^d   Kelestimur, F ^e   Kianmanesh, R ^f   Knigge, U ^g   Oberg K ^h   Pavel, M ^a   Perren, A ⁱ   Toumpanakis, C ^j   O'Connor, J ^k   Krenning, E ^l   Reed, N ^m   O'Toole, D ⁿ  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HOSPITAL SÍRIO LIBANÊS   (Brazil)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^f SERVICE DE DERMATOLOGIE   (France)

^g University of Copenhagen   (Denmark)

^h UPPSALA UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j ROYAL FREE HOSPITAL   (United Kingdom)

^k INSTITUTO ALEXANDER FLEMING   (Argentina)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

ⁿ ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A;

APPENDECTOMY; APPENDIX TUMOR; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CELL INVASION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIAGNOSTIC PROCEDURE; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; APPENDICEAL NEOPLASMS; EUROPE; NEUROENDOCRINE TUMORS; PATHOLOGY;

APPENDICEAL NEOPLASMS; EUROPE; HUMANS; NEUROENDOCRINE TUMORS;

EID: 84953774821     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000443165     Document Type: Conference Paper

References (72)

1. Yao JC, Hassan M, Phan A, et al: One hundred years after 'carcinoid': epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States. J Clin Oncol 2008; 26:3063-3072.
2. Allan B, Davis J, Perez E, et al: Malignant neu-roendocrine tumors: incidence and outcomes in pediatric patients. Eur J Pedatr Surg 2013; 23, 394-399.
3. Anwar K, Desai M, Al-Bloushi N, et al: Prevalence and clinicopathological characteristics of appendiceal carcinoids in Sharjah (United Arab Emirates). World J Gastrointest Oncol 2014; 6:253-256.
4. Benedix F, Reimer A, Gastinger I, et al: Primary appendiceal carcinoma-epidemiology, surgery and survival: results of a German multi-center study. EJSO 2010; 36:763-771.
5. Boxberger N, Redlich A, Böger C, et al: Neu-roendocrine tumors of the appendix in children and adolescents. Pediatr Blood Cancer 2013; 60:65-70.
6. Ellis L, Shale MJ, Coeman MP: Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastro-enterol 2010; 105:2563-2569.
7. In't Hoff KH, van der Wal HC, Kazemier G, et al: Carcinoid tumour of the appendix: an analysis of 1, 485 consecutive emergency appendectomies. J Gastrointest Surg 2008; 12: 1436-1438.
8. Hauso O, Gustafsson BI, Kidd M, et al: Neu-roendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008; 113:2655-2664.
9. Lepage C, Rachet B, Coleman MP: Survival from malignant digestive endocrine tumors in England and Wales: a population based study. Gastroenterology 2007; 132:899-904.
10. Modlin IM, Lye KD, Kidd M: A five-decade analysis of 13, 715 carcinoid tumors. Cancer 2003; 97:934-959.
11. Quaedvlieg PF, Visser O, Lamers CB, et al: Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epi-demiological study with 2, 391 patients. Ann Oncol 2001; 12:1295-1300.
12. Tsai HJ, Wu CC, Tsai CR, et al: The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PLoS One 2013; 8:e62487.
13. Gouffon M, Iff S, Ziegler K, et al: Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland. Swiss Med Wkly 2014; 144:w13924.
14. Hsu C, Rashid A, Xing Y, et al: Varying malignant potential of appendiceal neuroendo-crine tumors: importance of histologic subtype. J Surg Oncol 2013; 107:136-143.
15. Graham RPD, Williams NP, West KA: Primary epithelial tumours of the appendix in a black population: a review of cases. World J Gastroenterol 2009; 15:1472-1474.
16. Ito T, Sasano H, Tanaka M, et al: Epidemio-logical study of gastroenteropancreatic neu-roendocrine tumors in Japan. J Gastroenterol 2010; 45:234-243.
17. Scott A, Upadhyay V: Carcinoid tumors of the appendix in children in Auckland, New Zealand: 1965-2008. NZ Med J 2011; 124:56-60.
18. Zhang X, Ma L, Bao H, et al: Clinical, pathological and prognostic characteristics of gas-troenteropancreatic neuroendocrine neoplasms in China: a retrospective study. BMC Endocr Disord 2014; 14:54.
19. Mullen JT, Savarese DMF: Carcinoid tumors of the appendix: a population-based study. J Surg Oncol 2011; 104:41-44.
20. Crea N, Pata G, Di Betta E, et al: High incidence of appendix carcinoid tumors among candidates for bariatric surgery: diagnostic and therapeutic implications. Obes Surg 2011; 21:151-156.
21. Gustaffson BI, Siddique L, Chan A, et al: Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy. Int J Oncol 2008; 33:1121-1131.
22. Niederle MB, Hackl M, Kaserer K, et al: Gas-troenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroen-docrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 2010; 17:909-918.
23. Helland SK, Prosch AM, Viste A: Carcinoid tumours in the gastrointestinal tract-A population-based study from western Norway. Scand J Surg 2006; 95:158-161.
24. Lepage C, Bouvier AM, Manfredi S, et al: Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol 2006; 101:2826-2832.
25. García-Carbonero R, Capdevila J, Crespo-Herrero G, et al: Incidence, patterns of care and prognostic factors for outcome of gas-troenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol 2010; 21:1794-1803.
26. Ploeckinger U, Kloeppel G, Wiedenmann B, et al: The German NET registry: an audit on the diagnosis and therapy of neuroendocrine tumours. Neuroendocrinology 2009; 90:349-363.
27. Prommegger R, Obrist P, Ensinger C, et al: Retrospective evaluation of carcinoid tumors of the appendix in children. World J Surg 2002; 26:1489-1492.
28. Parkes SE, Muir KR, Sheyyab M, et al: Carci-noid tumours of the appendix in children 1957-1986: incidence, treatment and outcome. Br J Surg 1993; 80:502-504.
29. Kulkarni KP, Sergi C: Appendix carcinoids in childhood: long-term experience at a single institution in Western Canada and systematic review. Pediatr Int 2013; 55:157-162.
30. McGory ML, Maggard MA, Kang H, et al: Malignancies of the appendix: beyond case series reports. Dis Colon Rectum 2005; 48: 2264-2271.
31. Landry CS, Woodall C, Scoggins, et al: Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system. Arch Surg 2008; 143:664-670.
32. Moertel CG, Dockerty MB, Judd ES: Carci-noid tumors of the vermiform appendix. Cancer 1968; 21:270-278.
33. McCusker ME, Cote TR, Clegg LX, et al: Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer 2002; 94:3307-3312.
34. Niederle MB, Niederle B: Diagnosis and treatment of gastroenteropancreatic neuroendo-crine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation. Oncologist 2011; 16:602-613.
35. Goede AC, Caplin ME, Winslet MC: Carci-noid tumour of the appendix. Br J Surg 2003; 90:1317-1322.
36. Groth SS, Virnig BA, Al-Refaie WB, et al: Ap-pendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival. J Surg Oncol 2011; 103:39-45.
37. Moertel CG, Weiland LH, Nagorney DM, et al: Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 1987; 317: 1699-1701.
38. Stinner B, Rothmund M: Neuroendocrine tumours (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol 2005; 19:729-738.
39. Deans GT, Spence RA: Neoplastic lesions of the appendix. Br J Surg 1995; 82:299-306.
40. O'Donnell ME, Carson J, Garstin WIH, et al: Surgical treatment of malignant carcinoid tumours of the appendix. Int J Clin Pract 2007; 61:431-437.
41. Shapiro R, Eldar S, Sadot E, et al: Appendiceal cracinoid at a large tertiary center: pathologic findings and long-term follow-up evaluation. Am J Surg 2011; 201:805-808.
42. Coursey CA, Nelson RC, Moreno RD, et al: Carcinoid tumours of the appendix: are these tumors identifiable prospectively on preop-erative CT? Am Surg 2010; 76:273-275.
43. Debnath D, Rees J, Myint F: Are we missing diagnostic opportunities in cases of carcinoid tumors of the appendix? Surgeon 2008; 6:266-272.
44. Pickhardt PJ, Levy AD, Rohrmann CA, et al: Primary neoplasms of the appendix: radiolog-ic spectrum of disease with pathologic correlation. Radiographics 2003; 23:645-662.
45. Virgone C, Cecchetto G, Alagio A, et al: Ap-pendiceal neuroendocrine tumours in childhood: Italian TREP project. J Pediatr Gastro-enterol Nutr 2014; 58:333-338.
46. Pape UF, Perren A, Niederle B, et al: ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendo-crinology 2012; 95:135156.
47. Prommegger R, Ensinger C, Adlassnig C, et al: Catestatin-A novel neuropeptide in carci-noid tumors of the appendix. Anticancer Res 2004; 24:311-316.
48. Modlin IM, Kidd M, Latich I, et al: Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg 2006; 244:52-60.
49. O'Toole D, Grossman A, Gross D, et al: ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers. Neuroendocrinology 2009; 90:194-202.
50. Klimstra DS, Arnold R, Capella C, et al: Bos-man FT, Carneiro F, Hruban RH, Theise ND (eds): WHO Classification of Tumours of the Digestive System. Lyon, IARC, 2010.
51. Sobin LH, Gospodarowicz MK, Wittekind C (eds): TNM Classification of Malignant Tumours. Chichester, Wiley and Blackwell, 2009.
52. Rindi G, Klöppel G, Couvelard A, et al: TNM staging of midgut and hindgut (neuro)endo-crine tumors: a consensus proposal including a grading system. Virchows Arch 2007; 451: 757-762.
53. Tang LH, Shia J, Soslow RA, et al: Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol 2008; 32: 1429-1443.
54. Volante M, Daniele L, Asioli F, et al: Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix. Am J Surg Pathol 2013; 37:606-612.
55. Washington MK, Tang LH, Berlin J, et al: Protocol for the examination of specimens from patients with neuroendocrine tumors (carci-noid tumors) of the appendix. Arch Pathol Lab Med 2010; 134:171-175.
56. Tang LH: Epithelial neoplasms of the appendix. Arch Pathol Lab Med 2010; 134:1612-1620.
57. Moertel CG, Weiland LH, Telander RL: Car-cinoid tumor of the appendix in the first two decades of life. J Pediatr Surg 1990; 25:1073-1075.
58. Fornaro R, Frascio M, Sticchi S, et al: Appendectomy or right hemicolectomy in the treatment of appendiceal carcinoid tumors? Tu-mori 2007; 93:587-590.
59. Alexandraki KI, Griniatsos J, Bramis KI, et al: Clinical value of right hemicolectomy for ap-pendiceal carcinoids using pathologic criteria. J Endocrinol Invest 2011; 34:255-259.
60. Bamboat ZM, Berger DL: Is right hemicolec-tomy for 2.0-cm appendiceal carcinoids justified? Arch Surg 2006; 141:349-352.
61. Dunn JP: Carcinoid tumours of the appendix: 21 cases, with a review of the literature. NZ Med J 1982; 95:73-76.
62. Rossi G, Valli R, Bertolini F, et al: Does meso-appendix infiltration predict a worse prognosis in incidental neuroendocrine tumors of the appendix? A clinicopathologic and immu-nohistochemical study of 15 cases. Am J Clin Pathol 2003; 120:706-711.
63. Henderson L, Fehily C, Folaranmi S, et al: Management and outcome of neuroendo-crine tumours of the appendix-A two centre UK experience. J Pediatr Surg 2014; 49:1513-1517.
64. Arnold R, Chen YJ, Costa F, et al: ENETS consensus guidelines for the standards of care in neuroendocrine tumours: follow-up and documentation. Neuroendocrinology 2009; 90: 227-233.
65. Murray SE, Lloyd RV, Sippel RS, et al: Postoperative surveillance of small appendiceal carcinoid tumors. Am J Surg 2014; 207:342-345.
66. Lamarca A, Nonaka D, Lopez Escola C, Hub-ner RA, O'Dwyer S, Chakrabarty B, Fulford P, Valle JW: Appendiceal goblet cell carcinoids: management considerations from a reference peritoneal tumour service centre and ENETS Centre of Excellence. Neuroendocrinology DOI:10.1159/000440725.
67. Delle Fave G, O'Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, Ferone D, Ito T, Weber W, Zheng-Pei Z, De Herder WW, Pascher A, Ruszniewski P; all other Vienna Consensus Conference participants: ENETS consensus guidelines update for gastroduodenal neuro-endocrine neoplasms. Neuroendocrinology 2016; 103:119-124.
68. Niederle B, Pape UF, Costa F, Gross D, Kele-stimur F, Knigge U, Öberg K, Pavel M, Perren A, Toumpanakis C, O'Connor J, O'Toole D, Krenning E, Reed N, Kianmanesh R; all other Vienna Consensus Conference participants: ENETS consensus guidelines update for neu-roendocrine neoplasm of the jejunum and ileum. Neuroendocrinology 2016; 103:125-138.
69. Ramage JK, De Herder WW, Delle Fave G, Ferolla P, Ferone D, Ito T, Ruszniewski P, Sundin A, Weber W, Zheng-Pei Z, Taal B, Pascher A; all other Vienna Consensus Conference participants: ENETS consensus guidelines update for colorectal neuroendo-crine neoplasms. Neuroendocrinology 2016; 103:139-143.
70. Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, Kos-Kudla B, Kwek-keboom D, Rindi G, Klöppel G, Reed N, Kian-manesh R, Jensen RT; all other Vienna Consensus Conference participants: ENETS consensus guidelines update for the management of patients with functional pancreatic neuro-endocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendo-crinology 2016; 103:153-171.
71. Pavel M, O'Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E, Knigge U, Salazar R, Pape UF, Öberg K; all other Vienna Consensus Conference participants: ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendo-crine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology 2016; 103:172-185.
72. Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, Sed-lackova E, Toumpanakis C, Anlauf M, Cwikla JB, Caplin M, O'Toole D, Perren A; all other Vienna Consensus Conference participants: ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neu-roendocrinology 2016; 103:186-194.